C07K 14/54
Interleukins [il]
Official title: Interleukins [IL]
C07K14/54 (Interleukins [il]) appears on 3,300 US grants and 5,296 published applications in this corpus.
Search patents in C07K- Granted patents
- 3,300
- Published applications
- 5,296
- Assignees
- 1,701
- Inventors
- 8,338
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 5 | 0 |
| 1984 | 2 | 0 |
| 1985 | 6 | 0 |
| 1986 | 7 | 0 |
| 1987 | 14 | 0 |
| 1988 | 20 | 0 |
| 1989 | 20 | 0 |
| 1990 | 20 | 0 |
| 1991 | 29 | 0 |
| 1992 | 21 | 0 |
| 1993 | 22 | 0 |
| 1994 | 33 | 0 |
| 1995 | 39 | 0 |
| 1996 | 44 | 0 |
| 1997 | 83 | 0 |
| 1998 | 105 | 0 |
| 1999 | 110 | 0 |
| 2000 | 77 | 0 |
| 2001 | 78 | 10 |
| 2002 | 79 | 86 |
| 2003 | 64 | 189 |
| 2004 | 37 | 132 |
| 2005 | 43 | 122 |
| 2006 | 60 | 90 |
| 2007 | 81 | 186 |
| 2008 | 55 | 100 |
| 2009 | 96 | 127 |
| 2010 | 76 | 121 |
| 2011 | 72 | 118 |
| 2012 | 73 | 99 |
| 2013 | 59 | 98 |
| 2014 | 72 | 146 |
| 2015 | 68 | 96 |
| 2016 | 73 | 134 |
| 2017 | 76 | 145 |
| 2018 | 87 | 182 |
| 2019 | 108 | 263 |
| 2020 | 169 | 345 |
| 2021 | 213 | 398 |
| 2022 | 184 | 406 |
| 2023 | 161 | 469 |
| 2024 | 199 | 512 |
| 2025 | 235 | 406 |
| 2026 | 125 | 316 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- IL-10 muteins6 Oct 2026US 12,753,217 B2Universite De Lille
- Drug-specific pharmacokinetic assay for IL-15 superagonist6 Oct 2026US 12,754,189 B2NantCell, Inc.
- Fusion polypeptide and polypeptide dimer, and use thereof29 Sep 2026US 12,747,275 B2Nanjing Normal University
- Cytokine immunotherapy22 Sep 2026US 12,742,182 B2VLP Therapeutics, LLC
- K562 universal antigen presenting cells and uses thereof15 Sep 2026US 12,734,239 B2Board of Regents, The University of Texas System
- Recombinant expression vector for secreting interleukin-12, and attenuated salmonella strain transformed therewith8 Oct 2026US 2026/0306555 A1The Industry & Academic Cooperation in Chungnam National University (IAC)
- Fusion proteins of il-24 and immunostimulatory cytokines, nk cells expressing il-24 or fusion proteins, and methods of use thereof8 Oct 2026US 2026/0308218 A1Virginia Commonwealth University
- Recombinant herpes simplex virus with il-12 expression8 Oct 2026US 2026/0308219 A1
- Human interleukin-2 variant or derivative thereof8 Oct 2026US 2026/0308220 A1Jiangsu Hengrui Medicine Co., Ltd.
- Multi-receptor natural killer cells8 Oct 2026US 2026/0308225 A1Board of Regents, The University of Texas System
Most cited
By later US patents
- Interleukin-1α antibodies1,029US 8,034,337 B2Xbiotech, Inc. · 2011
- Methods for in vitro recombination882US 5,605,793 AAffymax Technologies N.V. · 1997
- Methods and compositions for cellular and metabolic engineering844US 5,837,458 AMaxygen, Inc. · 1998
- DNA mutagenesis by random fragmentation and reassembly791US 5,830,721 AAffymax Technologies N.V. · 1998
- Methods for generating polynucleotides having desired characteristics by iterative selection and recombination707US 5,811,238 AAffymax Technologies N.V. · 1998